Effects of Pioglitazone and Metformin Combination Therapy on High-Molecular-Weight Adiponectin Compared With Metformin Monotherapy in Type 2 Diabetes Mellitus Patients

被引：0
|
作者：
Matsushita, Takaya
Kaji, Akino
Kaji, Kuniaki
Takahashi, Eri
Usui, Takahiro
Asahi, Nobuteru
Sato, Tomoya
Ohono, Atushi
Ueki, Akio
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2490-PO
引用
收藏
页码：A626 / A626
页数：1
相关论文
共 50 条
  • [21] Metformin monotherapy for adults with type 2 diabetes mellitus
    Gnesin, Filip
    Thuesen, Anne Cathrine Baun
    Kahler, Lise Katrine Aronsen
    Madsbad, Sten
    Hemmingsen, Bianca
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [22] Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
    Kovacs, Christopher S.
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : 1773 - 1788
  • [23] Secondary Metformin Monotherapy Failure in Type 2 Diabetes Mellitus Patients
    Weiss, Tracey
    Iglay, Kristy
    Verma, Priya
    Rajpathak, Swapnil
    Yang, Lingfeng
    Blonde, Lawrence
    DIABETES, 2019, 68
  • [24] Effects of pioglitazone or voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with type 2 diabetes
    Aso, Yoshimasa
    Yamamoto, Ruriko
    Suetsugu, Mariko
    Matsumoto, Sachiko
    Wakabayashi, Sadao
    Matsutomo, Rika
    Takebayashi, Kohzo
    Inukai, Toshihiko
    DIABETES, 2007, 56 : A87 - A87
  • [25] Efficacy and safety of linagliptine in combination with metformin in patients with type 2 diabetes uncontrolled on metformin monotherapy
    Taskinen, M. -R.
    Rosenstock, J.
    Tamminen, I.
    Kubiak, R.
    Patel, S.
    Dugi, K. A.
    Tocque-le Goussee, E.
    Woerle, H. -J.
    DIABETES & METABOLISM, 2011, 37 : A107 - A108
  • [26] Effects of Metformin and Pioglitazone on Serum Pentosidine Levels in Type 2 Diabetes Mellitus
    Kanazawa, I.
    Yamamoto, M.
    Yamaguchi, T.
    Sugimoto, T.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (06) : 362 - 365
  • [27] Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Rosenstock, J.
    Rood, J.
    Cobitz, A.
    Biswas, N.
    Chou, H.
    Garber, A.
    DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 650 - 660
  • [28] Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes
    Wainstein, J.
    Katz, L.
    Engel, S. S.
    Xu, L.
    Golm, G. T.
    Hussain, S.
    O'Neill, E. A.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2012, 14 (05): : 409 - 418
  • [29] The efficacy of pioglitazone compared to metformin in drug naive patients with type 2 diabetes
    Schernthaner, G
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    DIABETES, 2003, 52 : A455 - A455
  • [30] Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus
    Tian Li
    Rui Providencia
    Nan Mu
    Yue Yin
    Mai Chen
    Yishi Wang
    Manling Liu
    Lu Yu
    Chunhu Gu
    Heng Ma
    Cardiovascular Diabetology, 20
12345